Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Valvular Heart Disease

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 282 articles:
HTML format



Single Articles


    November 2022
  1. SALMASI MY, Morris-Rosendahl D, Jarral OA, Rosendahl U, et al
    Determining the genetic contribution in patients with non-syndromic ascending thoracic aortic aneurysms: Correlation with findings from computational pathology.
    Int J Cardiol. 2022;366:1-9.
    PubMed     Abstract available


  2. FRANCIA P, Silvetti G, Cosentino P, Cristiano E, et al
    Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;366:42-47.
    PubMed     Abstract available


    October 2022
  3. ALI LA, Marrone C, Martins DS, Khraiche D, et al
    Prognostic factors in hypertrophic cardiomyopathy in children: An MRI based study.
    Int J Cardiol. 2022;364:141-147.
    PubMed     Abstract available


  4. ANDREASSEN K, Dejgaard LA, Lie O, Fink TS, et al
    Exercise training during childhood and adolescence is associated with favorable diastolic function in hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;364:65-71.
    PubMed     Abstract available


  5. SCOTTI A, Sturla M, Coisne A, Assafin M, et al
    Monitoring conduction disturbances following TAVR: Feasibility study of early discharge using a novel telemetry patch.
    Int J Cardiol. 2022;364:35-37.
    PubMed     Abstract available


  6. MUSICANTE M, Kim HH, Chen Y, Liao F, et al
    Regulation of endothelial nitric oxide synthase in cardiac remodeling.
    Int J Cardiol. 2022;364:96-101.
    PubMed     Abstract available


    September 2022
  7. LERMAN TT, Levi A, Kornowski R
    Meta-analysis of short- and long-term clinical outcomes of the self-expanding Evolut R/pro valve versus the balloon-expandable Sapien 3 valve for transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01385.
    PubMed     Abstract available


  8. GESKE JB, Gersh BJ
    Explaining unexplained syncope in hypertrophic cardiomyopathy: A clinical dilemma.
    Int J Cardiol. 2022;363:125-126.
    PubMed    


  9. HIGUCHI S, Orban M, Adamo M, Giannini C, et al
    Sex-specific impact of anthropometric parameters on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation.
    Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01337.
    PubMed     Abstract available


  10. DI MAURO M, Russo M, Saitto G, Lio A, et al
    Prognostic role of endocarditis in isolated tricuspid valve surgery. A propensity-weighted study.
    Int J Cardiol. 2022 Sep 13. pii: S0167-5273(22)01330.
    PubMed     Abstract available


  11. FANG M, Li B, Li X, Wang Y, et al
    MicroRNA-29b regulates pyroptosis involving calcific aortic valve disease through the STAT3/SOCS1 pathway.
    Int J Cardiol. 2022 Sep 2. pii: S0167-5273(22)01196.
    PubMed     Abstract available


  12. LILLO R, Graziani F
    Pregnancy in hypertrophic cardiomyopathy: New data, old questions.
    Int J Cardiol. 2022;362:126-127.
    PubMed    


  13. SHINTANI Y, Nakayama T, Masaki A, Yokoi M, et al
    Clinical impact of the pathological quantification of myocardial fibrosis and infiltrating T lymphocytes using an endomyocardial biopsy in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;362:110-117.
    PubMed     Abstract available


  14. OJEDA S, Pan M
    Aortic annuli in transcatheter valve implantation: "The bigger is not the better".
    Int J Cardiol. 2022;362:57-58.
    PubMed    


    August 2022
  15. NEDIOS S, Steven D, Sultan A
    Atrioventricular coupling in hypertrophic cardiomyopathy: Partners in crime for new-onset atrial fibrillation.
    Int J Cardiol. 2022 Aug 18. pii: S0167-5273(22)01195.
    PubMed    


  16. AMAT-SANTOS IJ, Blasco-Turrion S, Avanzas P
    Micro-dislodgement of Acurate neo 2 transcatheter heart valve: The right shoe for Cinderella.
    Int J Cardiol. 2022;361:29-30.
    PubMed    


  17. GALLO F, Gallone G, Kim WK, Reifart J, et al
    Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry.
    Int J Cardiol. 2022;361:55-60.
    PubMed     Abstract available


  18. FISCHLEIN T, Caporali E, Folliguet T, Kappert U, et al
    Randomized controlled trial between conventional versus sutureless bioprostheses for aortic valve replacement: Impact of mini and full sternotomy access at 1-year follow-up.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01179.
    PubMed     Abstract available


  19. SAVVOULIDIS P, Mechery A, Lawton E, Ludman PF, et al
    Comparison of left ventricular with right ventricular rapid pacing on tamponade during TAVI.
    Int J Cardiol. 2022;360:46-52.
    PubMed     Abstract available


  20. SICARI R
    Diagnosing HCM severity: The role of microvascular impairment.
    Int J Cardiol. 2022;360:44.
    PubMed    


    July 2022
  21. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    PubMed     Abstract available


  22. AUNG H, Eleid MF
    Thrombocytopenia as a marker of poor prognosis following transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 18. pii: S0167-5273(22)01096.
    PubMed    


  23. VELY M, L'official G, Galli E, Kosmala W, et al
    Functional tricuspid regurgitation: A clustering analysis and prognostic validation of three echocardiographic phenotypes in an external cohort.
    Int J Cardiol. 2022 Jul 16. pii: S0167-5273(22)01088.
    PubMed     Abstract available


  24. MOOLLA M, Mathew A, John K, Yogasundaram H, et al
    Outcomes of pregnancy in women with hypertrophic cardiomyopathy: A systematic review.
    Int J Cardiol. 2022;359:54-60.
    PubMed     Abstract available


  25. AGUIAR ROSA S, Lopes LR, Branco L, Galrinho A, et al
    Blunted coronary flow velocity reserve is associated with impairment in systolic function and functional capacity in hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;359:61-68.
    PubMed     Abstract available


  26. ALPERI A, Robichaud M, Panagides V, Mesnier J, et al
    Impact of residual transvalvular gradient on clinical outcomes following valve-in-valve transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Jul 4. pii: S0167-5273(22)01024.
    PubMed     Abstract available


  27. DILORENZO MP, DeCost G, Mai AD, Hughes N, et al
    Comparison of serum biomarkers of myocardial fibrosis with cardiac magnetic resonance in patients operated for tetralogy of Fallot.
    Int J Cardiol. 2022;358:27-33.
    PubMed     Abstract available


  28. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    New-generation Ultra and PRO devices: Latest device iterations but old valve type effects.
    Int J Cardiol. 2022;358:83-84.
    PubMed    


  29. KIM WK, Renker M, Dorr O, Nef H, et al
    Micro-dislodgement of a self-expanding transcatheter heart valve: Incidence, predictors, and outcomes.
    Int J Cardiol. 2022;358:77-82.
    PubMed     Abstract available


    June 2022
  30. RHEUDE T, Pellegrini C, Allali A, Bleiziffer S, et al
    Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut.
    Int J Cardiol. 2022;357:115-120.
    PubMed     Abstract available


  31. MASCIA G, Crotti L, Groppelli A, Canepa M, et al
    Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis.
    Int J Cardiol. 2022;357:88-94.
    PubMed     Abstract available


  32. KARDOS A, Rusinaru D, Marechaux S, Alskaf E, et al
    Implementation of a CT-derived correction factor to refine the measurement of aortic valve area and stroke volume using Doppler echocardiography improves grading of severity and prediction of prognosis in patients with severe aortic stenosis.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00917.
    PubMed     Abstract available


  33. SOLLI CN, Chamat-Hedemand S, Elming H, Ngo A, et al
    Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00928.
    PubMed     Abstract available


  34. MEUCCI MC, Fortuni F, Galloo X, Bootsma M, et al
    Left atrioventricular coupling index in hypertrophic cardiomyopathy and risk of new-onset atrial fibrillation.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00916.
    PubMed     Abstract available


  35. LANDES U, Morelli O, Danenberg H, Sathananthan J, et al
    Transcatheter aortic valve-in-valve implantation to treat aortic Para-valvular regurgitation after TAVI.
    Int J Cardiol. 2022 Jun 11. pii: S0167-5273(22)00913.
    PubMed     Abstract available


    May 2022
  36. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    PubMed     Abstract available


  37. CASTRO-MEJIA AF, Amat-Santos I, Ortega-Armas ME, Baz JA, et al
    Development of atrioventricular and intraventricular conduction disturbances in patients undergoing transcatheter aortic valve replacement with new generation self-expanding valves: A real world multicenter analysis.
    Int J Cardiol. 2022 May 9. pii: S0167-5273(22)00665.
    PubMed     Abstract available


  38. MATSUSHITA K, Marchandot B, Kibler M, Heger J, et al
    P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement.
    Int J Cardiol. 2022 May 4. pii: S0167-5273(22)00583.
    PubMed     Abstract available


  39. MONDA E, Lioncino M, Palmiero G, Franco F, et al
    Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
    Int J Cardiol. 2022;354:22-28.
    PubMed     Abstract available


    April 2022
  40. SADEGHIPOUR P, Farrashi M, De Caterina R
    Response to "non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial".
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00637.
    PubMed    


  41. CARBONE RG
    Advancements in calcific aortic valve disease.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00568.
    PubMed    


  42. PANAGIDES V, Kalavrouziotis D, Dumont E, Delarochelliere R, et al
    Carotid ultrasound following Transcarotid Transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00570.
    PubMed     Abstract available


  43. YALCIN YC, Veenis JF, Brugts JJ, Antonides CFJ, et al
    Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00555.
    PubMed     Abstract available


  44. ZORZI A, Brunetti G, Corrado D
    Differential diagnosis between athlete's heart and hypertrophic cardiomyopathy: New pieces of the puzzle.
    Int J Cardiol. 2022;353:77-79.
    PubMed    


  45. AUTORE C, Ferrazzi P
    Patients with hypertrophic cardiomyopathy are getting older.
    Int J Cardiol. 2022;353:73-74.
    PubMed    


  46. BOUREAU AS, Karakachoff M, Le Scouarnec S, Capoulade R, et al
    Heritability of aortic valve stenosis and bicuspid enrichment in families with aortic valve stenosis.
    Int J Cardiol. 2022 Apr 12. pii: S0167-5273(22)00501.
    PubMed     Abstract available


  47. KASTENGREN M, Settergren M, Ruck A, Feldt K, et al
    Percutaneous plug-based vascular closure device in 1000 consecutive transfemoral transcatheter aortic valve implantations.
    Int J Cardiol. 2022 Apr 12. pii: S0167-5273(22)00513.
    PubMed     Abstract available


  48. JOLOBE OMP
    Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00509.
    PubMed    


  49. LI L, Dai M, Fu Y
    Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00508.
    PubMed    


  50. PANAGIDES V, Mohammadi S, Rodes-Cabau J
    Cranial nerve injury: A word of caution for transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Apr 7. pii: S0167-5273(22)00497.
    PubMed    


  51. WEGENER A, Holm AE, Gomes LC, Lima KO, et al
    Prevalence of rheumatic heart disease in adults from the Brazilian Amazon Basin.
    Int J Cardiol. 2022;352:115-122.
    PubMed     Abstract available


    March 2022
  52. GOEL A, Malik AH, Gupta R, Rawal H, et al
    Concomitant tricuspid valve repair in patients undergoing mitral valve surgery: A recent update.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00388.
    PubMed    


  53. SADEGHIPOUR P, Pouraliakbar H, Parsaee M, Shojaeifard M, et al
    RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00396.
    PubMed     Abstract available


  54. MENNINI FS, Meucci F, Pesarini G, Vandoni P, et al
    Cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in low surgical risk aortic stenosis patients.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00393.
    PubMed     Abstract available


  55. MCGRATH D, Zhan Y
    Cranial nerve injury: A word of caution for transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00390.
    PubMed    


  56. SANTOS-MARTINEZ S, Halim J, Castro-Mejia A, De Marco F, et al
    Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances.
    Int J Cardiol. 2022;351:25-31.
    PubMed     Abstract available


  57. ARGIRO A, Rosenblum H, Griffin J, Batra J, et al
    Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysis.
    Int J Cardiol. 2022;351:78-83.
    PubMed     Abstract available


  58. TARASOUTCHI F, Rosa VEE
    Rivaroxaban effects on cardiac valve calcifications, renal preservation and inflammatory modulation: Have we found the panacea?
    Int J Cardiol. 2022;351:89-90.
    PubMed    


  59. ALBUQUERQUE AM, Brophy JM
    Pacemaker risk following transcatheter aortic valve replacement - A Bayesian reanalysis.
    Int J Cardiol. 2022 Mar 11. pii: S0167-5273(22)00328.
    PubMed     Abstract available


  60. RENKER M, Kim WK
    Assessment of frailty prior to TAVI: Can it now be measured objectively?
    Int J Cardiol. 2022;350:104-105.
    PubMed    


  61. WERNER N, Renker M, Dorr O, Bauer T, et al
    Anatomical suitability and off-label use of contemporary transcatheter heart valves.
    Int J Cardiol. 2022;350:96-103.
    PubMed     Abstract available


    February 2022
  62. LIMONGELLI G, Monda E
    Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure.
    Int J Cardiol. 2022 Feb 22. pii: S0167-5273(22)00265.
    PubMed    


  63. CHARITOS E, Kim WK
    Conduction disturbances following transcatheter aortic valve implantation: Any room for improvement?
    Int J Cardiol. 2022 Feb 16. pii: S0167-5273(22)00252.
    PubMed    


  64. MASSERA D, Xia Y, Li B, Riedy K, et al
    Mitral annular calcification in hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;349:83-89.
    PubMed     Abstract available


  65. TABATA N, Tsujita K
    Disparities in transcatheter mitral valve repair - Disparities being corrected little by little?
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00245.
    PubMed    


  66. SALA A, Lorusso R, Alfieri O
    Isolated tricuspid regurgitation: A plea for early correction.
    Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
    PubMed     Abstract available


  67. TIRADO-CONTE G, Salazar CH, McInerney A, Cruz-Utrilla A, et al
    Incidence, clinical impact and predictors of thrombocytopenia after transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Feb 3. pii: S0167-5273(22)00198.
    PubMed     Abstract available


    January 2022
  68. PANAGIDES V, Kalavrouziotis D, Dumont E, Delarochelliere R, et al
    Cranial nerve injury during transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Jan 31. pii: S0167-5273(22)00187.
    PubMed     Abstract available


  69. YA'QOUB L, Alkhouli M, Elgendy IY
    Symptomatic improvement using the New York Heart Association classification as a predictor for survival after transcatheter edge-to-edge repair of the mitral valve.
    Int J Cardiol. 2022 Jan 23. pii: S0167-5273(22)00132.
    PubMed    


  70. REDDAVID C, Costa G, Valvo R, Criscione E, et al
    Transcatheter aortic valve implantation during COVID-19 pandemic: An optimized model to relieve healthcare system overload.
    Int J Cardiol. 2022 Jan 22. pii: S0167-5273(22)00128.
    PubMed     Abstract available


  71. ZHANG C, Liu M, Wang X, Chen S, et al
    Mechanism of CircANKRD36 regulating cell heterogeneity and endothelial mesenchymal transition in aortic valve stromal cells by regulating miR-599 and TGF-beta signaling pathway.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00134.
    PubMed     Abstract available


  72. LECLERCQ F, Lorca L, Agullo A, Bouchdoug K, et al
    Evolution of right ventricular dysfunction and tricuspid regurgitation after TAVI: A prospective study.
    Int J Cardiol. 2022 Jan 20. pii: S0167-5273(22)00123.
    PubMed     Abstract available


  73. HASSOUN R, Budde H, Zhazykbayeva S, Herwig M, et al
    Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
    Int J Cardiol. 2022;347:44-45.
    PubMed    


  74. FUMAGALLI C, De Filippo V, Zocchi C, Tassetti L, et al
    Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2022 Jan 11. pii: S0167-5273(22)00069.
    PubMed     Abstract available


    December 2021
  75. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    Valve type selection for bicuspid aortic valves in TAVR: Does the key lie in the annular size?
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02049.
    PubMed    


  76. SUDO M, Sugiura A, Treiling L, Al-Kassou B, et al
    Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement - A novel CT-based marker for the prediction of pulmonary hypertension and outcome.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02011.
    PubMed     Abstract available


  77. NEGRI F, Muser D, Driussi M, Sanna GD, et al
    Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.
    Int J Cardiol. 2021;345:61-67.
    PubMed     Abstract available


  78. MASCIA G, Olivotto I, Brugada J, Arbelo E, et al
    Sport practice in hypertrophic cardiomyopathy: running to stand still?
    Int J Cardiol. 2021;345:77-82.
    PubMed     Abstract available


  79. ALPERI A, Pascual I, Avanzas P, Moris C, et al
    Atrial-FMR: No longer the forgotten mechanism of functional mitral regurgitation.
    Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)01999.
    PubMed    


  80. HEIDARI B, Ahmad A, Al-Hijji MA, Aoun J, et al
    Muscle fat index is associated with frailty and length of hospital stay following transcatheter aortic valve replacement in high-risk octogenarians.
    Int J Cardiol. 2021 Dec 3. pii: S0167-5273(21)01978.
    PubMed     Abstract available


  81. HASSOUN R, Budde H, Zhazykbayeva S, Herwig M, et al
    Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;344:160-169.
    PubMed     Abstract available


    November 2021
  82. BENFARI G, Cavalcante JL, Enriquez-Sarano M
    Multimodality imaging in functional mitral regurgitation: Valvular disease and the chamber remodeling quantification.
    Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01955.
    PubMed    


  83. MOSCARELLA E, Mangieri A, Giannini F, Tchetche D, et al
    Annular size and interaction with trans-catheter aortic valves for treatment of severe bicuspid aortic valve stenosis: Insights from the BEAT registry.
    Int J Cardiol. 2021 Nov 26. pii: S0167-5273(21)01871.
    PubMed     Abstract available


  84. RUBBIO AP, Testa L, Grasso C, Sisinni A, et al
    Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation insights from the multi-center MITRA-TUNE registry.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01844.
    PubMed     Abstract available


  85. WENZL FA, Ambrosini S, Paneni F
    Molecular underpinnings of myocardial stiffness in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;343:80-82.
    PubMed    


  86. KHAN U, Shaw T, Kempny A, Gatzoulis MA, et al
    The clinical presentation and outcome of aortic coarctation associated with left ventricular inflow and outflow tract lesion in adult patients: Shone syndrome and beyond.
    Int J Cardiol. 2021;343:45-49.
    PubMed     Abstract available


  87. PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
    Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
    PubMed     Abstract available


  88. GIORDANO A, Biondi-Zoccai G, Finizio F, Ferraro P, et al
    Characteristics and outcomes of MitraClip in octogenarians: Evidence from 1853 patients in the GIOTTO registry.
    Int J Cardiol. 2021;342:65-71.
    PubMed     Abstract available


    October 2021
  89. HASIN T, Mann D, Welt M, Barrett O, et al
    Loss of left ventricular rotation is a significant determinant of functional mitral regurgitation.
    Int J Cardiol. 2021 Oct 6. pii: S0167-5273(21)01509.
    PubMed     Abstract available


  90. AL-MOHAMMAD A
    The impact of cMR on echocardiographic markers of severe aortic regurgitation, a story of synergy.
    Int J Cardiol. 2021 Oct 5. pii: S0167-5273(21)01503.
    PubMed    


  91. BENITO-GONZALEZ T, Carrasco-Chinchilla F, Estevez-Loureiro R, Pascual I, et al
    Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation.
    Int J Cardiol. 2021 Oct 2. pii: S0167-5273(21)01497.
    PubMed     Abstract available


  92. SIONTIS KC, Liu K, Bos JM, Attia ZI, et al
    Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents.
    Int J Cardiol. 2021;340:42-47.
    PubMed     Abstract available


    September 2021
  93. FUJITA H, Toba T, Miwa K, Suzuki M, et al
    The impact of computed tomography-derived aortic atheroma volume on prognosis after transcatheter aortic valve replacement.
    Int J Cardiol. 2021 Sep 30. pii: S0167-5273(21)01494.
    PubMed     Abstract available


  94. GEYER M, Keller K, Tamm AR, Born S, et al
    Early symptomatic benefit indicates long-term prognosis after transcatheter mitral valve edge-to-edge repair in functional and degenerative etiology.
    Int J Cardiol. 2021 Sep 23. pii: S0167-5273(21)01479.
    PubMed     Abstract available


  95. MONDA E, Palmiero G, Lioncino M, Rubino M, et al
    External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis.
    Int J Cardiol. 2021;339:99-101.
    PubMed     Abstract available


  96. PAPANASTASIOU CA, Zegkos T, Kokkinidis DG, Parcharidou D, et al
    Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2021;339:108.
    PubMed    


  97. EL KHOUDARY SR, Fabio A, Yester JW, Steinhauser ML, et al
    Design and rationale of a clinical trial to increase cardiomyocyte division in infants with tetralogy of Fallot.
    Int J Cardiol. 2021;339:36-42.
    PubMed     Abstract available


  98. RODRIGUES T, Raposo SC, Brito D, Lopes LR, et al
    Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review.
    Int J Cardiol. 2021;339:83-92.
    PubMed     Abstract available


  99. YA'QOUB L, Jneid H, Elgendy IY
    Transcatheter edge-to-edge repair of the mitral valve: A promising bridge to heart transplant for select patients?
    Int J Cardiol. 2021 Sep 9. pii: S0167-5273(21)01330.
    PubMed    


  100. XU YP, Zhang P
    Letter on "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis".
    Int J Cardiol. 2021;338:152.
    PubMed    


  101. NAMDAR M, Richardot P, Johner N, Shah D, et al
    Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures.
    Int J Cardiol. 2021;338:121-126.
    PubMed     Abstract available


  102. KAWASHIMA H, Serruys PW, Mylotte D, Rosseel L, et al
    Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available.
    Int J Cardiol. 2021;338:168-173.
    PubMed     Abstract available


  103. FABI M, Calicchia M, Palleri D, Ndikubwimana I, et al
    Pediatric rheumatic carditis in Italy and Rwanda: The same disease, different socio-economic settings.
    Int J Cardiol. 2021;338:154-160.
    PubMed     Abstract available


  104. BABAPOOR-FARROKHRAN S, Pressman GS
    Mitral annular disjunction: A myocardial abnormality too?
    Int J Cardiol. 2021;338:174-175.
    PubMed    


    August 2021
  105. GAO SA, Polte CL, Lagerstrand KM, Bech-Hanssen O, et al
    The usefulness of left ventricular volume and aortic diastolic flow reversal for grading chronic aortic regurgitation severity - Using cardiovascular magnetic resonance as reference.
    Int J Cardiol. 2021 Aug 30. pii: S0167-5273(21)01311.
    PubMed     Abstract available


  106. QIN L, Chen C, Gu S, Zhou M, et al
    A radiomic approach to predict myocardial fibrosis on coronary CT angiography in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;337:113-118.
    PubMed     Abstract available


    July 2021
  107. WONG I, Sondergaard L, De Backer O
    Computational simulation models to test bioprosthetic aortic valves: A valuable alternative or addition to bench testing?
    Int J Cardiol. 2021 Jul 30. pii: S0167-5273(21)01200.
    PubMed    


  108. CATERINAA M, Andreaa R, Pompiliob F
    Aortic valve stenosis burden: Where we are now?
    Int J Cardiol. 2021 Jul 19. pii: S0167-5273(21)01177.
    PubMed    


  109. ROBERTS-THOMSON RL, Baumann AAW, Reade J, Culgan L, et al
    Surgical and percutaneous management of Aboriginal Australians with rheumatic heart disease: Timeliness and concordance between practice and guidelines.
    Int J Cardiol. 2021;335:80-84.
    PubMed     Abstract available


  110. HINOJAR R, Gomez AG, Garcia-Martin A, Monteagudo JM, et al
    Impact of right ventricular systolic function in patients with significant tricuspid regurgitation. A cardiac magnetic resonance study.
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01168.
    PubMed     Abstract available


  111. KAMPAKTSIS PN, Tzoumas A
    LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis."
    Int J Cardiol. 2021;334:86-87.
    PubMed    


  112. WANG TKM, Kwon DH, Abou-Hassan O, Chetrit M, et al
    Strain evaluation for mitral annular disjunction by echocardiography and magnetic resonance imaging: A case-control study.
    Int J Cardiol. 2021;334:154-156.
    PubMed     Abstract available


    June 2021
  113. DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
    Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
    PubMed     Abstract available


  114. PELLICCIA F, Pasceri V
    The less-is-better effect: The case of alcohol dose in septal ablation for hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;333:143-144.
    PubMed    


  115. MARTIN M, Junco-Vicente A, Rodriguez I
    Bicuspid aortopathy in adolescents: Another piece of the puzzle.
    Int J Cardiol. 2021;333:94-95.
    PubMed    


  116. NARANG R, Saxena A, Ramakrishnan S, Gupta SK, et al
    An evidence-based scoring system to diagnose acute rheumatic fever with carditis in children.
    Int J Cardiol. 2021;333:146-151.
    PubMed     Abstract available


  117. RODRIGUEZ-GABELLA T, Zimarino M, Barbanti M, Testa L, et al
    Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study.
    Int J Cardiol. 2021;333:69-76.
    PubMed     Abstract available


  118. VESELKA J, Faber L, Liebregts M, Cooper R, et al
    Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2021;333:127-132.
    PubMed     Abstract available


  119. MOSCARELLI M, Gallo F, Gallone G, Kim WK, et al
    Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2021 Jun 6. pii: S0167-5273(21)00911.
    PubMed     Abstract available


  120. UY J, Ketkar AG, Portnoy A, Kim JJ, et al
    Cost-utility analysis of heart surgeries for young adults with severe rheumatic mitral valve disease in India.
    Int J Cardiol. 2021 Jun 4. pii: S0167-5273(21)00916.
    PubMed     Abstract available


  121. PAPANASTASIOU CA, Zegkos T, Karamitsos TD, Rowin EJ, et al
    Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2021;332:127-132.
    PubMed     Abstract available


  122. MAGRI D, Gallo G
    Cardiopulmonary exercise testing: An increasingly important step in managing hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;332:138-139.
    PubMed    


  123. SARRAJ-ASIL A, Diez-Villanueva P
    Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
    Int J Cardiol. 2021 Jun 1. pii: S0167-5273(21)00903.
    PubMed     Abstract available


    May 2021
  124. VON KAPPELGAARD L, Gislason G, Davidsen M, Zwisler AD, et al
    Temporal trends and socioeconomic differences in treatment and mortality following a diagnosis of aortic stenosis.
    Int J Cardiol. 2021 May 27. pii: S0167-5273(21)00896.
    PubMed     Abstract available


  125. WANG Z, Zhao L, He S
    Prognostic nutritional index and the risk of mortality in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;331:152-157.
    PubMed     Abstract available


  126. SEGGEWISS H, Batzner A
    Surgical myectomy in HOCM: Still gold standard for septal reduction?
    Int J Cardiol. 2021;331:174-175.
    PubMed    


  127. TOME ESTEBAN MT
    Gender disease-dose in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;331:172-173.
    PubMed    


  128. D'ASCENZO F, Bruno F, Baldetti L, De Filippo O, et al
    Aortic valve replacement vs. balloon-expandable and self-expandable transcatheter implantation: A network meta-analysis.
    Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00811.
    PubMed     Abstract available


  129. OOMS JF, Ceusters J, Hirsch A, Budde RPJ, et al
    Accuracy of three-dimensional computational modeling in prediction of the dynamic neo left ventricular outflow tract with transcatheter mitral valve replacement.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00814.
    PubMed     Abstract available


  130. VILADES D, Garcia-Moll X, Gomez-Llorente M, Pujadas S, et al
    Differentiation of athlete's heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae.
    Int J Cardiol. 2021;330:232-237.
    PubMed     Abstract available


  131. MUKAI K
    Cardiac magnetic resonance T1 mapping: A novel quality assurance program paving the way towards standardization and wider clinical practice.
    Int J Cardiol. 2021;330:266-267.
    PubMed    


  132. YAMAMURA K, Duarte V, Karur GR, Graf J, et al
    The impact of pulmonary valve replacement on pregnancy outcomes in women with tetralogy of Fallot.
    Int J Cardiol. 2021;330:43-49.
    PubMed     Abstract available


  133. ZHANG Q, Werys K, Popescu IA, Biasiolli L, et al
    Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials - A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study.
    Int J Cardiol. 2021;330:251-258.
    PubMed     Abstract available


  134. XU F, Chen Y, Tillman KA, Cui Y, et al
    Characterizing modifier genes of cardiac fibrosis phenotype in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;330:135-141.
    PubMed     Abstract available


    April 2021
  135. TRIMAILLE A, Hmadeh S, Matsushita K, Schini-Kerth V, et al
    Reply to "Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study" by Comella et al.
    Int J Cardiol. 2021 Apr 29. pii: S0167-5273(21)00747.
    PubMed    


  136. LI C, Tang D, Yao J, Shao Y, et al
    Porcine and bovine aortic valve comparison for surgical optimization: A fluid-structure interaction modeling study.
    Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00740.
    PubMed     Abstract available


  137. DEKANY G, Fontos G, Satish S, Szabo G, et al
    The prognostic value of immediate post-TAVI hemodynamic evaluation is superior to aortography and transoesophageal echocardiography in predicting patient survival.
    Int J Cardiol. 2021;329:153-161.
    PubMed     Abstract available


  138. MIDTBO H, Hauge SW, Haaverstad R, Dalen H, et al
    How reproducible is the diagnosis of borderline rheumatic heart disease?
    Int J Cardiol. 2021;328:163-164.
    PubMed    


  139. BATZNER A, Aicha D, Pfeiffer B, Neugebauer A, et al
    Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy - Time for a new definition?
    Int J Cardiol. 2021;328:117-121.
    PubMed     Abstract available


  140. PRADEGAN N, Leon-Wyss JR, Iribarren JR, Garcia E, et al
    Contemporary trends in surgical rheumatic valve disease in a Caribbean nation.
    Int J Cardiol. 2021;328:215-217.
    PubMed     Abstract available


  141. KHARBANDA RK, Lodder L, Ragab AAY, de Jong PL, et al
    Early and late post-operative arrhythmias after surgical myectomy: 45 years of follow-up.
    Int J Cardiol. 2021;328:63-68.
    PubMed     Abstract available


    March 2021
  142. GIANNINI C, Angelillis M, Fiorina C, Tamburino C, et al
    Clinical impact and evolution of mitral regurgitation after TAVI using the new generation self-expandable valves.
    Int J Cardiol. 2021 Mar 31. pii: S0167-5273(21)00630.
    PubMed     Abstract available


  143. DE MARZO V, Dettori S, Nicolini LA, Vercellino M, et al
    Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study.
    Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00622.
    PubMed     Abstract available


  144. OH JK, Lee SH, Lee SA, Kang DY, et al
    Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00557.
    PubMed     Abstract available


  145. KIM WK, Doerr O, Renker M, Choi YH, et al
    Initial experience with a novel, modular, minimalistic approach for transfemoral aortic valve implantation.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00564.
    PubMed     Abstract available


  146. COMELLA A, Michail M, Chan J, Cameron JD, et al
    Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00566.
    PubMed     Abstract available


  147. LLOYD JW, Eleid MF
    Simplifying the approach to classical low-flow low-gradient severe aortic stenosis: A renewed emphasis on the resting transthoracic echocardiogram.
    Int J Cardiol. 2021 Mar 22. pii: S0167-5273(21)00547.
    PubMed    


  148. SIURANA JM, Sabate-Rotes A, Ayerza A, Jimenez L, et al
    Adolescents with bicuspid aortic valve: Which criteria should we use for aortic dilatation?
    Int J Cardiol. 2021 Mar 20. pii: S0167-5273(21)00545.
    PubMed     Abstract available


  149. JOSEPH N, Craft M, Mill L, Erickson CC, et al
    Assessment of mitral valve function in children and young adults with hypertrophic cardiomyopathy using three-dimensional echocardiography.
    Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00544.
    PubMed     Abstract available


  150. AMAT-SANTOS IJ, Barrero A
    New conduction abnormalities following aortic valve-in-valve: The weakest link of a strong chain.
    Int J Cardiol. 2021 Mar 18. pii: S0167-5273(21)00478.
    PubMed    


  151. MANCONE M, Infusino F, Fedele F, Sardella G, et al
    Transcervical approach for TAVI: Perhaps more than a fallback.
    Int J Cardiol. 2021;327:66-67.
    PubMed    


  152. SCOLARI FL, Faganello LS, Garbin HI, Piva E Mattos B, et al
    A systematic review of microRNAs in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;327:146-154.
    PubMed     Abstract available


  153. KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
    Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2021;327:117-124.
    PubMed     Abstract available


  154. BERNARD J, Tastet L, Capoulade R, Shen M, et al
    Left ventricular asymmetric remodeling and subclinical left ventricular dysfunction in patients with calcific aortic valve stenosis - Results from a subanalysis of the PROGRESSA study.
    Int J Cardiol. 2021 Mar 13. pii: S0167-5273(21)00474.
    PubMed     Abstract available


  155. HOKKEN TW, van Wiechen MP, Ooms JF, El Azzouzi I, et al
    Impact of Interventricular membranous septum length on pacemaker need with different Transcatheter aortic valve implantation systems.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00391.
    PubMed     Abstract available


  156. KELLERMAIR J, Saeed S, Chambers JB, Kammler J, et al
    Predictors of true-severe classical low-flow low-gradient aortic stenosis at resting echocardiography.
    Int J Cardiol. 2021 Mar 1. pii: S0167-5273(21)00381.
    PubMed     Abstract available


    February 2021
  157. XIE MY, Hou LJ
    LncRNA MALAT1 aggravates calcific aortic valve disease by sponging miR-195.
    Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00370.
    PubMed    


  158. KRALER S, Wenzl FA, Akhmedov A, Blaser MC, et al
    ApoA-I mimetics improve aortic stenosis-associated left-ventricular diastolic dysfunction but fail to benefit rabbit models with normal aortic valves.
    Int J Cardiol. 2021 Feb 21. pii: S0167-5273(21)00297.
    PubMed    


  159. AKODAD M, Aldhaheri E, Marin G, Roubille F, et al
    Transcatheter aortic valve replacement performed with selective telemetry monitoring: A prospective study.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00281.
    PubMed     Abstract available


  160. TENGLER A, Ulrich S, Fischer M, Pastor-Villaescusa B, et al
    Rationale and feasibility of transcatheter pulmonary valve implantation in small conduits with the Edwards Sapien valves.
    Int J Cardiol. 2021;325:45-50.
    PubMed     Abstract available


  161. STANKOWSKI T, Mangner N, Linke A, Aboul-Hassan SS, et al
    Cardiac conduction abnormalities in patients with degenerated bioprostheses undergoing transcatheter aortic valve-in-valve implantations and their impact on long-term outcomes.
    Int J Cardiol. 2021 Feb 13. pii: S0167-5273(21)00282.
    PubMed     Abstract available


  162. FIDOCK B, Archer G, Barker N, Elhawaz A, et al
    Standard and emerging CMR methods for mitral regurgitation quantification.
    Int J Cardiol. 2021 Feb 3. pii: S0167-5273(21)00148.
    PubMed     Abstract available


    January 2021
  163. WANG H, Song H, Yang Y, Wu Z, et al
    Morphology display and hemodynamic testing using 3D printing may aid in the prediction of LVOT obstruction after mitral valve replacement.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00110.
    PubMed     Abstract available


  164. LUQUE T, Noriega FJ, McInerney A, Travieso A, et al
    Impact of delirium in acute cardiac care unit after transcatheter aortic valve replacement.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00135.
    PubMed     Abstract available


  165. REIFART J, Liebetrau C, Weferling M, Dorr O, et al
    Single versus double use of a suture-based closure device for transfemoral aortic valve implantation.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00125.
    PubMed     Abstract available


  166. ANDO T, Onishi T, Tobaru T
    Extremely severe aortic stenosis - Is TAVR the answer?
    Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00085.
    PubMed    


  167. VALLABHAJOSYULA S, Vallabhajosyula S, Yang LT, Rabinstein AA, et al
    Frequency of intracranial aneurysms and sub-arachnoid hemorrhage is significantly lesser in bicuspid aortic valve than aortic coarctation.
    Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00127.
    PubMed     Abstract available


  168. KOFFLARD MJM
    Pacing in hypertrophic obstructive cardiomyopathy: First choice therapy in low volume centers?
    Int J Cardiol. 2021;323:199-200.
    PubMed    


  169. DORSCH LM, Kuster DWD, Jongbloed JDH, Boven LG, et al
    The effect of tropomyosin variants on cardiomyocyte function and structure that underlie different clinical cardiomyopathy phenotypes.
    Int J Cardiol. 2021;323:251-258.
    PubMed     Abstract available


  170. HUURMAN R, Schinkel AFL, de Jong PL, van Slegtenhorst MA, et al
    Impact of sex on timing and clinical outcome of septal myectomy for obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;323:133-139.
    PubMed     Abstract available


  171. KONECNY T, Khoo M, Covassin N, Edelhofer P, et al
    Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;323:155-160.
    PubMed     Abstract available


  172. NACHAR W, Merlet N, Maafi F, Mihalache-Avram T, et al
    ApoA-I mimetic does not improve left ventricular diastolic dysfunction in rabbits without aortic valve stenosis.
    Int J Cardiol. 2021 Jan 6. pii: S0167-5273(20)34337.
    PubMed     Abstract available


  173. SAJI M, Higuchi R, Izumi Y, Takamisawa I, et al
    Transcatheter aortic valve replacement in patients with extremely severe aortic stenosis.
    Int J Cardiol. 2021 Jan 5. pii: S0167-5273(20)34328.
    PubMed     Abstract available


  174. MICELI A, Di Bacco L, Donatelli F, Glauber M, et al
    Can we solve two problems with a TAVR?
    Int J Cardiol. 2021;322:95-96.
    PubMed    


  175. JAVIDGONBADI D, Andersson B, Abdon NJ, Ostman-Smith I, et al
    Morbidity and resource usage after myectomy- or pacing-treatment in hypertrophic obstructive cardiomyopathy: A case-control study.
    Int J Cardiol. 2021;322:197-203.
    PubMed     Abstract available


  176. RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
    Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
    Int J Cardiol. 2021;322:272-277.
    PubMed     Abstract available


    December 2020
  177. IACOVELLI F, Pignatelli A, Cafaro A, Stabile E, et al
    Impact of contrast medium osmolality on the risk of acute kidney injury after transcatheter aortic valve implantation: Insights from the magna Graecia TAVI registry.
    Int J Cardiol. 2020 Dec 23. pii: S0167-5273(20)34297.
    PubMed     Abstract available


  178. KHERALLAH RY, Harrison D, Preventza O, Silva GV, et al
    Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis.
    Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34302.
    PubMed     Abstract available


  179. USUKU H, Yamamoto E, Noguchi M, Komorita T, et al
    Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease.
    Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34301.
    PubMed     Abstract available


  180. ALI FM, Ong G, Edwards J, Connelly KA, et al
    Comparison of transcatheter tricuspid valve repair using the MitraClip NTR and XTR systems.
    Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34244.
    PubMed     Abstract available


  181. TRIPATHI B, Sawant AC, Sharma P, Tandon V, et al
    Short term outcomes after transcatheter mitral valve repair.
    Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34219.
    PubMed     Abstract available


    November 2020
  182. PASCANER AF, Houriez-Gombaud-Saintonge S, Craiem D, Gencer U, et al
    Comprehensive assessment of local and regional aortic stiffness in patients with tricuspid or bicuspid aortic valve aortopathy using magnetic resonance imaging.
    Int J Cardiol. 2020 Nov 28. pii: S0167-5273(20)34169.
    PubMed     Abstract available


  183. LU H, Monney P, Fournier S, Pavon AG, et al
    Transcervical approach versus transfemoral approach for transcatheter aortic valve replacement.
    Int J Cardiol. 2020 Nov 23. pii: S0167-5273(20)34149.
    PubMed     Abstract available


  184. CHENG YY, Chow V, Brieger D, Yan TD, et al
    Outcomes of 16,436 patients requiring isolated aortic valve surgery: A statewide cohort study.
    Int J Cardiol. 2020 Nov 9. pii: S0167-5273(20)34084.
    PubMed     Abstract available


  185. MONDA E, Limongelli G
    The hospitalizations in hypertrophic cardiomyopathy: "The dark side of the moon".
    Int J Cardiol. 2020;318:101-102.
    PubMed    


  186. MAOR E, Barbash IM
    TAVR review of reviews: A new view on the horizon.
    Int J Cardiol. 2020;318:43-44.
    PubMed    


    October 2020
  187. IELASI A, Moscarella E, Mangieri A, Giannini F, et al
    Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis undergoing trans-catheter valve replacement with new generation devices: Insight from the BEAT international collaborative registry.
    Int J Cardiol. 2020 Oct 22. pii: S0167-5273(20)34003.
    PubMed     Abstract available


  188. ANDO T, Adegbala O, Aggarwal A, Afonso L, et al
    Redo aortic valve intervention after transcatheter aortic valve replacement: Analysis of the nationwide readmission database.
    Int J Cardiol. 2020 Oct 22. pii: S0167-5273(20)33991.
    PubMed     Abstract available


  189. ZHANG Y, Fan P, Zhang H, Ma W, et al
    Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
    Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
    PubMed     Abstract available


  190. LESSICK J
    Is CMR the gold standard for evaluating transvalvular flow?
    Int J Cardiol. 2020;317:221-222.
    PubMed    


  191. JENSEN JK, Poulsen SH
    Left atrial systolic function by strain analysis - A new useful prognostic tool in primary severe mitral regurgitation?
    Int J Cardiol. 2020 Oct 6. pii: S0167-5273(20)33911.
    PubMed    


  192. YILDIRIM OT, Ozgeyik M, Ozgeyik MO
    Safety of transcatheter aortic valve replacement at malignancy patients.
    Int J Cardiol. 2020 Oct 4. pii: S0167-5273(20)33907.
    PubMed    


    September 2020
  193. SUN W, Qu L
    Upregulation of microRNA-195 might be a novel therapeutic target in the treatment of aortic valve calcification.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33803.
    PubMed    


  194. MANDOLI GE, Pastore MC, Benfari G, Bisleri G, et al
    Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33743.
    PubMed     Abstract available


  195. RONG LQ, Hameed I, Di Franco A, Rahouma MM, et al
    A pairwise meta-analytic comparison of aortic valve area determined by planimetric versus hemodynamic methods in aortic stenosis.
    Int J Cardiol. 2020 Sep 8. pii: S0167-5273(20)33737.
    PubMed     Abstract available


  196. CHASAPI A, Karogiannis N, Zidros S, Patel K, et al
    Determinants of outcome in patients with heart failure with reduced ejection fraction & secondary mitral regurgitation.
    Int J Cardiol. 2020 Sep 7. pii: S0167-5273(20)33731.
    PubMed     Abstract available


    August 2020
  197. GILL C, Lee M, Balanescu DV, Donisan T, et al
    Transcatheter and Surgical Aortic Valve Replacement Impact on Outcomes and Cancer Treatment Schedule.
    Int J Cardiol. 2020 Aug 25. pii: S0167-5273(20)33654.
    PubMed     Abstract available


  198. MORELLO A, Corcione N, Ferraro P, Cimmino M, et al
    The best way to transcatheter aortic valve implantation: From standard to new approaches.
    Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33563.
    PubMed     Abstract available


  199. GOEL R, Sartori S, Cao D, Claessen BE, et al
    Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry.
    Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33562.
    PubMed     Abstract available


  200. TERENTES-PRINTZIOS D, Gardikioti V, Aznaouridis K, Latsios G, et al
    The impact of transcatheter aortic valve implantation on arterial stiffness and wave reflections.
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33567.
    PubMed     Abstract available


  201. EDWARDS KS, Chow EKH, Dao C, Hossepian D, et al
    Impact of cognitive behavioral therapy on depression symptoms after transcatheter aortic valve replacement: A randomized controlled trial.
    Int J Cardiol. 2020 Aug 12. pii: S0167-5273(20)33534.
    PubMed     Abstract available


  202. FREA S, Pidello S, Boretto P, Rettegno S, et al
    Disproportionate functional mitral regurgitation predicts a favourable response after MitraClip implant in patients with advanced heart failure. Real-world evidence of a new conceptual framework.
    Int J Cardiol. 2020 Aug 11. pii: S0167-5273(20)33553.
    PubMed     Abstract available


    July 2020
  203. CAI S, Bowers N, Dhoot A, Ho EC, et al
    Natural history of severe tricuspid regurgitation: Outcomes after transcatheter tricuspid valve intervention compared to medical therapy.
    Int J Cardiol. 2020 Jul 16. pii: S0167-5273(20)33466.
    PubMed     Abstract available


  204. GOETTE A
    Atrial functional mitral regurgitation: A relavant factor for fibrillatory atrial cardiomyopathy prognosis?
    Int J Cardiol. 2020 Jul 15. pii: S0167-5273(20)33460.
    PubMed    


  205. REDDY SC, Zhang J, Jani V, Wolfe SB, et al
    Left ventricular myocardial deformation as measure of hemodynamic burden in congenital valvular aortic stenosis.
    Int J Cardiol. 2020 Jul 14. pii: S0167-5273(20)33456.
    PubMed     Abstract available


  206. ORBAN M, Orban M, Hausleiter J, Braun D, et al
    Tricuspid regurgitation and right ventricular dysfunction after cardiac device implantation - Is it time for intra-procedural TEE-guided lead implantation?
    Int J Cardiol. 2020 Jul 13. pii: S0167-5273(20)33458.
    PubMed    


  207. COMPAGNONE M, Marchetti G, Taglieri N, Ghetti G, et al
    Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Int J Cardiol. 2020 Jul 5. pii: S0167-5273(20)33411.
    PubMed     Abstract available


  208. LU F, Qiao F, Lv Y, An Z, et al
    A radial force-independent bioprosthesis for transcatheter tricuspid valve implantation in a preclinical model.
    Int J Cardiol. 2020 Jul 4. pii: S0167-5273(20)33448.
    PubMed     Abstract available


    June 2020
  209. KIM K, Kitai T, Kaji S, Pak M, et al
    Outcomes and predictors of cardiac events in medically treated patients with atrial functional mitral regurgitation.
    Int J Cardiol. 2020 Jun 28. pii: S0167-5273(20)33420.
    PubMed     Abstract available


  210. ANDELL P, Li X, Martinsson A, Nilsson PM, et al
    Neighborhood socioeconomic status and aortic stenosis: A Swedish study based on nationwide registries and an echocardiographic screening cohort.
    Int J Cardiol. 2020 Jun 28. pii: S0167-5273(20)33412.
    PubMed     Abstract available


  211. KAVSUR R, Hupp H, Sugiura A, Ozturk C, et al
    Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation.
    Int J Cardiol. 2020 Jun 26. pii: S0167-5273(20)33409.
    PubMed     Abstract available


  212. MATHEW J, Nguyen A, Nishimura RA, Geske JB, et al
    Septal Myectomy in patients with previous coronary revascularization - hypertrophic cardiomyopathy masquerading as ischemic heart disease.
    Int J Cardiol. 2020 Jun 19. pii: S0167-5273(20)33393.
    PubMed     Abstract available


  213. SAEED S, Smith J, Grigoryan K, Lysne V, et al
    The tricuspid annular plane systolic excursion to systolic pulmonary artery pressure index: Association with all-cause mortality in patients with moderate or severe tricuspid regurgitation.
    Int J Cardiol. 2020 Jun 5. pii: S0167-5273(20)31030.
    PubMed     Abstract available


  214. RUBINO AS, Torella M, Della Ratta EE, Galbiati D, et al
    Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study.
    Int J Cardiol. 2020 Jun 5. pii: S0167-5273(20)30777.
    PubMed     Abstract available


  215. SCARSINI R, Lunardi M, Venturi G, Pighi M, et al
    Long-term variations of FFR and iFR after transcatheter aortic valve implantation.
    Int J Cardiol. 2020 Jun 3. pii: S0167-5273(20)31098.
    PubMed     Abstract available


  216. KHAN M, Senguttuvan NB, Krishnamoorthy P, Vengrenyuk Y, et al
    Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement with medtronic self-expanding prosthesis: Insights from correlations with computer tomography.
    Int J Cardiol. 2020 Jun 1. pii: S0167-5273(20)32198.
    PubMed     Abstract available


    May 2020
  217. GUTIERREZ E, Martinez-Legazpi P, Bermejo J
    Hard events, stiff valves, stiff arteries and stiff ventricles: the complex interactions of degenerative aortic valve stenosis.
    Int J Cardiol. 2020 May 30. pii: S0167-5273(20)31686.
    PubMed    


  218. IANNOPOLLO G, Romano V, Buzzatti N, Ancona M, et al
    Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: The LIRA method.
    Int J Cardiol. 2020 May 27. pii: S0167-5273(20)33067.
    PubMed     Abstract available


  219. ILIADIS C, Metze C, Korber MI, Baldus S, et al
    Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair.
    Int J Cardiol. 2020 May 26. pii: S0167-5273(19)36336.
    PubMed     Abstract available


  220. PAPAGEORGIOU N, Falconer D, Wyeth N, Lloyd G, et al
    Effect of tricuspid regurgitation and right ventricular dysfunction on long-term mortality in patients undergoing cardiac devices implantation: >10-year follow-up study.
    Int J Cardiol. 2020 May 26. pii: S0167-5273(20)30403.
    PubMed     Abstract available


  221. AL-FARRA H, Abu-Hanna A, de Mol BAJM, Ter Burg WJ, et al
    External validation of existing prediction models of 30-day mortality after Transcatheter Aortic Valve Implantation (TAVI) in the Netherlands Heart Registration.
    Int J Cardiol. 2020 May 22. pii: S0167-5273(19)36171.
    PubMed     Abstract available


  222. WERNLY B, Muessig J, Lichtenauer M, Rouet P, et al
    Reply to: In searching for prognostic markers in transcatheter aortic valve replacement: Diastolic dysfunction and insulin-like growth factor system assessment.
    Int J Cardiol. 2020;307:136.
    PubMed    


  223. PFLUECKE C, Wydra S, Berndt K, Tarnowski D, et al
    Mon2-monocytes and increased CD-11b expression before transcatheter aortic valve implantation are associated with earlier death.
    Int J Cardiol. 2020 May 12. pii: S0167-5273(20)30913.
    PubMed     Abstract available


  224. WESTREICH R, Abramowitz Y
    Cancer in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: Is it malignant or benign?
    Int J Cardiol. 2020 May 11. pii: S0167-5273(20)31336.
    PubMed    


  225. DURAN KARADUMAN B, Ayhan H, Keles T, Bozkurt E, et al
    The playmaker of the mitral valve disease: Mitral annulus.
    Int J Cardiol. 2020 May 5. pii: S0167-5273(20)31547.
    PubMed    


  226. ZELIS JM, Meiburg R, Roijen J, Janssens KLPM, et al
    3D-printed stenotic aortic valve model to simulate physiology before, during, and after transcatheter aortic valve implantation.
    Int J Cardiol. 2020 May 4. pii: S0167-5273(20)30219.
    PubMed     Abstract available


    April 2020
  227. OZCINAR E
    Minimal invasive approach in mitral valve surgery: Evolving method which requires higher experience and skills.
    Int J Cardiol. 2020 Apr 17. pii: S0167-5273(20)31891.
    PubMed    


  228. FREITAS-FERRAZ AB, Nombela-Franco L, Urena M, Maes F, et al
    Transcatheter aortic valve replacement in patients with paradoxical low-flow, low-gradient aortic stenosis: Incidence and predictors of treatment futility.
    Int J Cardiol. 2020 Apr 13. pii: S0167-5273(20)31055.
    PubMed     Abstract available


  229. MC MORROW R, Kriza C, Urban P, Amenta V, et al
    Assessing the safety and efficacy of TAVR compared to SAVR in low-to-intermediate surgical risk patients with aortic valve stenosis: An overview of reviews.
    Int J Cardiol. 2020 Apr 11. pii: S0167-5273(19)35904.
    PubMed     Abstract available


  230. SAEED S, Saeed N, Grigoryan K, Chowienczyk P, et al
    Determinants and clinical significance of aortic stiffness in patients with moderate or severe aortic stenosis.
    Int J Cardiol. 2020 Apr 2. pii: S0167-5273(19)36394.
    PubMed     Abstract available


  231. CHEN Y, O'Mahony C
    The price and value of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.
    Int J Cardiol. 2020 Apr 2. pii: S0167-5273(20)30939.
    PubMed    


  232. WEBER L, Rickli H, Ammann P, Taramasso M, et al
    Hemodynamic profile of patients with severe aortic valve stenosis and atrial fibrillation versus sinus rhythm.
    Int J Cardiol. 2020 Apr 1. pii: S0167-5273(19)35939.
    PubMed     Abstract available


    March 2020
  233. GAVAZZONI M, Taramasso M, Zuber M, Pozzoli A, et al
    Functional mitral regurgitation and cardiac resynchronization therapy in the "era" of trans-catheter interventions: Is it time to move from a staged strategy to a tailored therapy?
    Int J Cardiol. 2020 Mar 28. pii: S0167-5273(19)35293.
    PubMed     Abstract available


  234. SOLER M, Minana G, Santas E, Nunez E, et al
    CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.
    Int J Cardiol. 2020 Mar 21. pii: S0167-5273(19)35557.
    PubMed     Abstract available


  235. MYAT A, Papachristofi O, Trivedi U, Bapat V, et al
    Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis.
    Int J Cardiol. 2020 Mar 21. pii: S0167-5273(19)36135.
    PubMed     Abstract available


  236. BAZ L, Wiesel M, Mobius-Winkler S, Westphal JG, et al
    Depression and anxiety in elderly patients with severe symptomatic aortic stenosis persistently improves after transcatheter aortic valve replacement (TAVR).
    Int J Cardiol. 2020 Mar 18. pii: S0167-5273(19)36351.
    PubMed     Abstract available


  237. BIANCARI F, Dahlbacka S, Juvonen T, Virtanen MPO, et al
    Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2020 Mar 18. pii: S0167-5273(19)35546.
    PubMed     Abstract available


  238. BALISTRERI CR
    To the research of treatments for the typical calcific disease of old aortic valve in the omics era: Is the miR-195 a therapeutic signature via targetable p38-MAPK/VWF axis in bicuspid aortic valve?
    Int J Cardiol. 2020 Mar 16. pii: S0167-5273(20)30509.
    PubMed    


  239. IMAMURA T
    Worsening of mitral regurgitation following transcatheter aortic valve replacement.
    Int J Cardiol. 2020;303:22.
    PubMed    


    February 2020
  240. DEHGHANI P, Singer Z, Morrison J, Booker J, et al
    Characteristics and usefulness of unintended premature ventricular contraction during invasive assessment of aortic stenosis.
    Int J Cardiol. 2020 Feb 28. pii: S0167-5273(20)30202.
    PubMed     Abstract available


  241. KALOGERAS K, Ruparelia N, Kabir T, Jabbour R, et al
    Comparison of the self-expanding Evolut-PRO transcatheter aortic valve to its predecessor Evolut-R in the real world multicenter ATLAS registry.
    Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)34112.
    PubMed     Abstract available


  242. KAUW D, Woudstra OI, van Engelen K, Meijboom FJ, et al
    22q11.2 deletion syndrome is associated with increased mortality in adults with tetralogy of Fallot and pulmonary atresia with ventricular septal defect.
    Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)35419.
    PubMed     Abstract available


  243. MICALI LR, Parise G, Moula AI, Alayed Y, et al
    Are recurrence of ischemic mitral regurgitation and left ventricular reverse remodeling after restrictive annuloplasty ring dependent?
    Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)34381.
    PubMed     Abstract available


  244. MAGNUSSON P, Wimo A
    Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults.
    Int J Cardiol. 2020 Feb 20. pii: S0167-5273(19)35600.
    PubMed     Abstract available


  245. GUIMARAES L, Ferreira-Neto AN, Urena M, Nombela-Franco L, et al
    Transcatheter aortic valve replacement with the balloon-expandable SAPIEN 3 valve: Impact of calcium score on valve performance and clinical outcomes.
    Int J Cardiol. 2020 Feb 19. pii: S0167-5273(19)35596.
    PubMed     Abstract available


  246. WATANABE Y, Nara Y, Hioki H, Kawashima H, et al
    Short-term effects of low-dose tolvaptan in acute decompensated heart failure patients with severe aortic stenosis: The LOHAS registry.
    Int J Cardiol. 2020 Feb 7. pii: S0167-5273(19)34524.
    PubMed     Abstract available


  247. LENIHAN DJ, Jimenez J
    Cardiac amyloidosis and hypertrophic cardiomyopathy: "You always have time to make an accurate diagnosis!"
    Int J Cardiol. 2020;300:205-206.
    PubMed    


  248. KALBACHER D, Daubmann A, Tigges E, Hunlich M, et al
    Impact f pre- and post-procedural renal dysfunction on long-term outcomes in patients undergoing MitraClip implantation: A retrospective analysis from two German high-volume centres.
    Int J Cardiol. 2020;300:87-92.
    PubMed    


  249. MAURIZI N, Rella V, Fumagalli C, Salerno S, et al
    Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy.
    Int J Cardiol. 2020;300:191-195.
    PubMed     Abstract available


    January 2020
  250. COISNE A, Ninni S, Pontana F, Aghezzaf S, et al
    Clinical significance of electrocardiographic markers of myocardial damage prior to aortic valve replacement.
    Int J Cardiol. 2020 Jan 29. pii: S0167-5273(19)33328.
    PubMed     Abstract available


  251. KIM K, Furukawa Y
    Sex-related differences in the response to exercise testing in asymptomatic aortic stenosis.
    Int J Cardiol. 2020 Jan 22. pii: S0167-5273(19)35899.
    PubMed    


  252. BERKOVITCH A, Barbash IM, Finkelstein A, Assali AR, et al
    Validation of cardiac damage classification and addition of albumin in a large cohort of patients undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2020 Jan 15. pii: S0167-5273(19)34869.
    PubMed     Abstract available


  253. YANG H, Bouma BJ, Dimopoulos K, Khairy P, et al
    Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.
    Int J Cardiol. 2020;299:123-130.
    PubMed     Abstract available


  254. LIMONGELLI G, Monda E, Tramonte S, Gragnano F, et al
    Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2020;299:186-191.
    PubMed     Abstract available


  255. SHAMSUDEEN I, Fei LYN, Burwash IG, Beauchesne L, et al
    Presentation and management of calcific mitral valve disease.
    Int J Cardiol. 2020 Jan 11. pii: S0167-5273(19)35036.
    PubMed     Abstract available


  256. YANG L, Wu D, Li M, Zhu X, et al
    Upregulation of microRNA-195 ameliorates calcific aortic valve disease by inhibiting VWF via suppression of the p38-MAPK signaling pathway.
    Int J Cardiol. 2020 Jan 8. pii: S0167-5273(19)33810.
    PubMed     Abstract available


    December 2019
  257. DE RONDE-TILLMANS MJAG, Goudzwaard JA, El Faquir N, van Mieghem NM, et al
    TAVI Care and Cure, the Rotterdam multidisciplinary program for patients undergoing transcatheter aortic valve implantation: Design and rationale.
    Int J Cardiol. 2019 Dec 16. pii: S0167-5273(19)30407.
    PubMed     Abstract available


    November 2019
  258. BEN-ASSA E, Biner S, Elmariah S, Banai S, et al
    Author's reply to: Worsening of mitral regurgitation following transcatheter aortic valve replacement.
    Int J Cardiol. 2019 Nov 30. pii: S0167-5273(19)34780.
    PubMed    


  259. SAEED S, Mancia G, Rajani R, Parkin D, et al
    Sex-differences in aortic stenosis: Effect on functional capacity and prognosis.
    Int J Cardiol. 2019 Nov 28. pii: S0167-5273(19)34571.
    PubMed     Abstract available


  260. PAPARELLA D, Fattouch K, Moscarelli M, Santarpino G, et al
    Current trends in mitral valve surgery: A multicenter national comparison between full-sternotomy and minimally-invasive approach.
    Int J Cardiol. 2019 Nov 26. pii: S0167-5273(19)35541.
    PubMed     Abstract available


  261. SEOUDY H, Kuhn C, Frank J, Eden M, et al
    Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2019 Nov 12. pii: S0167-5273(19)32508.
    PubMed     Abstract available


    October 2019
  262. WOITEK FJ, Stachel G, Kiefer P, Haussig S, et al
    Treatment of failed aortic bioprostheses: An evaluation of conventional redo surgery and transfemoral transcatheter aortic valve-in-valve implantation.
    Int J Cardiol. 2019 Oct 31. pii: S0167-5273(19)32470.
    PubMed     Abstract available


  263. KIM WK, Hamm CW
    TAVR for mixed aortic valve disease - A good companionship?
    Int J Cardiol. 2019 Oct 25. pii: S0167-5273(19)33870.
    PubMed    


  264. SPACCAROTELLA C, Mongiardo A, Sorrentino S, Indolfi C, et al
    Which hospital should be selected for readmission after TAVR?
    Int J Cardiol. 2019;293:107-108.
    PubMed    


  265. MUIESAN ML, Paini A, Salvetti M
    Antihypertensive drugs and outcome in aortic stenosis.
    Int J Cardiol. 2019 Oct 12. pii: S0167-5273(19)34542.
    PubMed    


  266. HAMDAN A, Kornowski R
    TAVI in bicuspid aortic valve stenosis.
    Int J Cardiol. 2019 Oct 12. pii: S0167-5273(19)34494.
    PubMed    


  267. RUSINARU D, Rietzschel ER, Bohbot Y, De Buyzere ML, et al
    Allometric versus ratiometric normalization of left ventricular stroke volume by Doppler-echocardiography for outcome prediction in severe aortic stenosis with preserved ejection fraction.
    Int J Cardiol. 2019 Oct 9. pii: S0167-5273(19)31998.
    PubMed     Abstract available


  268. LOSI MA, Mancusi C, Midtbo H, Saeed S, et al
    Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis.
    Int J Cardiol. 2019 Oct 3. pii: S0167-5273(18)36936.
    PubMed     Abstract available


    September 2019
  269. SAEED S, Mancia G, Rajani R, Parkin D, et al
    Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: Relationship with all-cause mortality.
    Int J Cardiol. 2019 Sep 7. pii: S0167-5273(19)32589.
    PubMed     Abstract available


  270. UESHIMA D, Nai Fovino L, Brener SJ, Fabris T, et al
    Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis.
    Int J Cardiol. 2019 Sep 6. pii: S0167-5273(19)33116.
    PubMed     Abstract available


  271. MORIS C, Avanzas P
    Long term TAVI: Only time will tell.
    Int J Cardiol. 2019;290:84-85.
    PubMed    


    August 2019
  272. BORREGAARD B, Dahl JS, Riber LPS, Ekholm O, et al
    Effect of early, individualised and intensified follow-up after open heart valve surgery on unplanned cardiac hospital readmissions and all-cause mortality.
    Int J Cardiol. 2019;289:30-36.
    PubMed     Abstract available


    July 2019
  273. DAYAN V, Zuasnabar A, Citro R, Bossone E, et al
    Aortopathy and regurgitation in bicuspid valve patients increase the risk of aortopathy in relatives.
    Int J Cardiol. 2019;286:117-120.
    PubMed     Abstract available


    June 2019
  274. VAN DE HEYNING CM, Ammirati E
    MitraClip system as bridge to left ventricular assist device in selected patients with advanced heart failure.
    Int J Cardiol. 2019 Jun 14. pii: S0167-5273(19)31653.
    PubMed    


    May 2019
  275. AMMIRATI E, Van De Heyning CM, Musca F, Brambatti M, et al
    Safety of centrifugal left ventricular assist device in patients previously treated with MitraClip system.
    Int J Cardiol. 2019;283:131-133.
    PubMed     Abstract available


    April 2019
  276. JEWGENOW P, Schneider H, Bokenkamp R, Horer J, et al
    Subclinical thrombus formation in bioprosthetic pulmonary valve conduits.
    Int J Cardiol. 2019;281:113-118.
    PubMed     Abstract available


  277. KIM WK, Brinkert M, Mangner N, Gatto F, et al
    Transfemoral implantation of the ACURATE neo prosthesis using a low-profile expandable introducer system: A multicenter registry.
    Int J Cardiol. 2019;281:76-81.
    PubMed     Abstract available


  278. HUANG MS, Lee WH, Tsai HR, Liu YW, et al
    Value of layer-specific strain distribution patterns in hypertrophied myocardium from different etiologies.
    Int J Cardiol. 2019;281:69-75.
    PubMed     Abstract available


  279. FERLINI M, Mauri S, Rossini R
    Dual antiplatelet therapy after TAVR: A drop in the bucket?
    Int J Cardiol. 2019;280:46-48.
    PubMed     Abstract available


  280. EGIDY ASSENZA G, Mariucci ME, Chiarabelli M, Donti A, et al
    First-in-human, off-label use of BeGraft(R) stenting of non-conduit, large right ventricular outflow tract for transcatheter valve landing zone preparation.
    Int J Cardiol. 2019;280:43-45.
    PubMed     Abstract available


    March 2019
  281. LOPES LR, Brito D, Belo A, Cardim N, et al
    Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy - An ancillary study of the Portuguese registry of hypertrophic cardiomyopathy.
    Int J Cardiol. 2019;278:173-179.
    PubMed     Abstract available


  282. DI LULLO L, Tripepi G, Ronco C, D'Arrigo G, et al
    Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor.
    Int J Cardiol. 2019;278:243-249.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: